Non-Interventional Study - Use of lorlatinib in treatment-naïve adult patients with metastatic or locally advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) from India. (B7461047)

18/03/2024
23/09/2024
EU PAS number:
EUPAS1000000025
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information